- Project Summary
- Study Duration
- Objectives
- Team Members
Project Summary
Study Duration
From December 2023
Objectives
To characterize immunologic biomarkers among vaccinated individuals from Euvichol-S Phase 3 trial. To describe the frequency of participants with evidence of recent past (the last 12 months) Vibrio cholerae infection based on immunologic biomarkers. To describe the frequency of self-reported diarrheal illness in the past 12 months.
Team Members
Principal Investigator(s): Dr. Dipesh Tamrakar, Prof. Dr. Rajeev Shrestha
Co-Investigator(s): Dr. Srijana Dangol, Dr. Shristi Jonchhe, Dr. Samita Adhikary, Dr. Mukul Upadhyaya Nepal, Dr. Sanket Kumar Mishra, Mr. Surendra Kumar Madhup
Project Coordinator: Dr. Shristi Jonchhe
Research Assistants: Ms.Reena Kharbuja, Ms. Menuka Dawadi, Ms. Sampada GC, Ms. Sona Gautam, Ms. Anusha Basnet, Ms. Laxmi Shova Hakuduwal, Ms. Sarita Gosain
Supported Partner: International Vaccine Institute
Collaborating Partners: International Vaccine Institute (IVI)









For more detailed Information, Please contact:Â rajeev.shrestha@kusms.edu.np / rmaleku@hotmail.com or dipesht@kusms.edu.np